US20070148168A1 - Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions - Google Patents

Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions Download PDF

Info

Publication number
US20070148168A1
US20070148168A1 US11/588,973 US58897306A US2007148168A1 US 20070148168 A1 US20070148168 A1 US 20070148168A1 US 58897306 A US58897306 A US 58897306A US 2007148168 A1 US2007148168 A1 US 2007148168A1
Authority
US
United States
Prior art keywords
method
s1p
immune
lpa
derived moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/588,973
Inventor
Roger Sabbadini
William Garland
Glenn Stoller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apollo Endosurgery Inc
Original Assignee
LPATH THERAPEUTICS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US11/261,935 priority Critical patent/US7794713B2/en
Application filed by LPATH THERAPEUTICS Inc filed Critical LPATH THERAPEUTICS Inc
Priority to US11/588,973 priority patent/US20070148168A1/en
Assigned to LPATH THERAPEUTICS, INC. reassignment LPATH THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: STOLLER, GLENN L., GARLAND, WILLIAM A., SABBADINI, ROGER A.
Priority claimed from US11/784,417 external-priority patent/US7862812B2/en
Publication of US20070148168A1 publication Critical patent/US20070148168A1/en
Priority claimed from US11/841,363 external-priority patent/US20080213274A1/en
Priority claimed from US12/098,419 external-priority patent/US20090074720A1/en
Assigned to LPATH, INC. reassignment LPATH, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LPATH THERAPEUTICS, INC.
Application status is Abandoned legal-status Critical

Links